bioRxiv / medRxiv
open access
CC BY-NC-ND 4.0
Recognition and Treatment of Primary Aldosteronism in the Updated Guideline Era
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Supplemental data on "Drug-Resistant Hypertension in A Large Registry of Primary Aldosteronism"#647621
- Prospective Study on Primary Aldosteronism in Resistant Hypertension#1045498
- The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans#1114338
- Repurposing Valsartan May Protect Against Pulmonary Hypertension#272466
- A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients#1088452
Record · ID 353188
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive